ONTOLOGY REPORT - ANNOTATIONS
|
abnormal epididymis morphology
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| S | TW | TAS | RGD:1004 | RGD | |||||||
abnormal estrous cycle
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | Egfr | epidermal growth factor receptor |
|
IED | 14 | 97,617,358 | 97,788,211 | RGD:70386 | RGD | ||
| G | Inha | inhibin alpha |
|
IED | 9 | 74,781,223 | 74,784,124 | RGD:2290396 | RGD | ||
abnormal fertility/fecundity
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| S | BP | TAS | RGD:1004 | RGD | |||||||
abnormal gubernaculum morphology
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| S | LE/Orl | Long-Evans/Cryptorchid | Spontaneous | IED | RGD:2301310 | RGD | |||||
abnormal prostate gland epithelium morphology
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| S | NBL | TAS | RGD:1004 | RGD | |||||||
abnormal prostate gland morphology
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| Q | Prcr1 | Prostate cancer resistance QTL 1 |
|
IAGP | 2 | 73,374,972 | 163,154,358 | RGD:1358944 | RGD | ||
| Q | Prcr2 | Prostate cancer resistance QTL 2 | IAGP | RGD:1358944 | RGD | ||||||
| Q | Prcs1 | Prostate cancer susceptibility QTL 1 |
|
IAGP | 19 | 16,245,310 | 36,472,155 | RGD:1358944 | RGD | ||
| Q | Prcs2 | Prostate cancer susceptibility QTL 2 |
|
IAGP | 20 | 4,740,609 | 18,411,969 | RGD:1358944 | RGD | ||
abnormal prostate gland physiology
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| Q | Prcr1 | Prostate cancer resistance QTL 1 |
|
IAGP | 2 | 73,374,972 | 163,154,358 | RGD:1358944 | RGD | ||
| Q | Prcr2 | Prostate cancer resistance QTL 2 | IAGP | RGD:1358944 | RGD | ||||||
| Q | Prcs1 | Prostate cancer susceptibility QTL 1 |
|
IAGP | 19 | 16,245,310 | 36,472,155 | RGD:1358944 | RGD | ||
| Q | Prcs2 | Prostate cancer susceptibility QTL 2 |
|
IAGP | 20 | 4,740,609 | 18,411,969 | RGD:1358944 | RGD | ||
abnormal Sertoli cell morphology
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| S | KH | IED | RGD:2301322 | RGD | |||||||
abnormal spermatogenesis
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | Brca2 | breast cancer 2, early onset |
|
IAGP | 12 | 4,282,952 | 4,323,693 | RGD:1599505 | RGD | ||
| S | AN | TAS | RGD:1004 | RGD | |||||||
| S | KH | IED | RGD:2301322 | RGD | |||||||
| S | LE/Orl | Long-Evans/Cryptorchid | IED | RGD:2301309 | RGD | ||||||
| S | W/Gaox | IED | RGD:2298497 | RGD | |||||||
abnormal vas deferens morphology
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| S | TW | TAS | RGD:1004 | RGD | |||||||
arrest of spermatogenesis
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | Gdnf | glial cell derived neurotrophic factor |
|
IEA | 2 | 57,399,312 | 57,424,030 | RGD:704404 | RGD | ||
| S | TT | TAS | RGD:1004 | RGD | |||||||
azoospermia
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | Fkbp6 | FK506 binding protein 6 |
|
IAGP | 12 | 22,474,002 | 22,544,784 | RGD:1582485 | RGD | ||
cryptorchism
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| S | KH | IED | RGD:2301322 | RGD | |||||||
| S | LE/Orl | Long-Evans/Cryptorchid | Model | IED | RGD:2301308 | RGD | |||||
decreased litter size
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| Q | Inf1 | Infertility severity QTL 1 |
|
IED | 8 | 26,358,063 | 71,358,063 | RGD:631224 | RGD | ||
decreased testis weight
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| Q | Teswt1 | Testicular weight QTL 1 |
|
IED | 7 | 85,089,895 | 100,273,797 | RGD:1625009 | RGD | ||
| Q | Teswt2 | Testicular weight QTL 2 |
|
IED | 1 | 202,790,380 | 247,790,380 | RGD:1625009 | RGD | ||
early sexual maturation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | Kiss1 | KiSS-1 metastasis-suppressor |
|
IED | 13 | 46,244,786 | 46,247,288 | RGD:2292180 | RGD | ||
enlarged testis
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | Fmr1 | fragile X mental retardation 1 |
|
IEA | X | 154,756,031 | 154,793,782 | RGD:704404 | RGD | ||
increased litter size
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | Inha | inhibin alpha |
|
IED | 9 | 74,781,223 | 74,784,124 | RGD:2290396 | RGD | ||
male infertility
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| S | KH | IED | RGD:2301322 | RGD | |||||||
| S | SD-Tg(Ubc-eGFP/ Dazl-shRNA)17-9GarRrrc | Dazl shRNA (17-9) | IED | RGD:1580353 | RGD | ||||||
| S | W/Gaox | IED | RGD:2298497 | RGD | |||||||
male pseudohermaphroditism
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| S | TF | TAS | RGD:1004 | RGD | |||||||
oligozoospermia
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| S | TA | TAS | RGD:1004 | RGD | |||||||
primary sex reversal
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | Fgf9 | fibroblast growth factor 9 |
|
IEA | 15 | 37,115,068 | 37,155,652 | RGD:704404 | RGD | ||
prostate gland epithelial hyperplasia
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| S | NBL | TAS | RGD:1004 | RGD | |||||||
prostate gland hyperplasia
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | Kdr | kinase insert domain receptor | IEP | RGD:2292079 | RGD | ||||||
| Q | Prcs1 | Prostate cancer susceptibility QTL 1 |
|
IAGP | 19 | 16,245,310 | 36,472,155 | RGD:1358944 | RGD | ||
| Q | Prcs2 | Prostate cancer susceptibility QTL 2 |
|
IAGP | 20 | 4,740,609 | 18,411,969 | RGD:1358944 | RGD | ||
| S | AXC | TAS | RGD:1004 | RGD | |||||||
| S | COP | TAS | RGD:1004 | RGD | |||||||
prostate gland hypoplasia
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| Q | Prcr1 | Prostate cancer resistance QTL 1 |
|
IAGP | 2 | 73,374,972 | 163,154,358 | RGD:1358944 | RGD | ||
| Q | Prcr2 | Prostate cancer resistance QTL 2 | IAGP | RGD:1358944 | RGD | ||||||
reduced female fertility
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | Adcy3 | adenylate cyclase 3 |
|
IED | 6 | 27,118,325 | 27,202,275 | RGD:704368 | RGD | ||
reduced male fertility
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| Q | Inf1 | Infertility severity QTL 1 |
|
IED | 8 | 26,358,063 | 71,358,063 | RGD:631224 | RGD | ||
reproductive system inflammation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| Q | Eutr1 | Estrogen induced uterine response QTL 1 |
|
IAGP | 5 | 1,220,773 | 79,863,911 | RGD:1559292 | RGD | ||
| Q | Eutr2 | Estrogen induced uterine response QTL 2 |
|
IAGP | 5 | 35,911,094 | 109,163,425 | RGD:1559291 | RGD | ||
small seminal vesicle
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| Q | Inf1 | Infertility severity QTL 1 |
|
IED | 8 | 26,358,063 | 71,358,063 | RGD:631224 | RGD | ||
testis hypoplasia
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | Fgf9 | fibroblast growth factor 9 |
|
IEA | 15 | 37,115,068 | 37,155,652 | RGD:704404 | RGD | ||
| S | KH | IED | RGD:2301322 | RGD | |||||||
testis inflammation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| S | LEW-Tg(HLA-B*2705m1,B2M)133-1Trg | QTM | RGD:731214 | RGD | |||||||
Term paths to the root
|
| ||||||||||||||||||




browse the term